Literature DB >> 24739522

Mammalian orthoreovirus T3D infects U-118 MG cell spheroids independent of junction adhesion molecule-A.

I J C Dautzenberg1, D J M van den Wollenberg1, S K van den Hengel1, R W A Limpens1, M Bárcena1, A J Koster1, R C Hoeben1.   

Abstract

In the canonical pathway, infection of cells by the wild-type mammalian orthoreovirus Type 3 Dearing (T3D) is dependent on the interaction of the viral spike protein σ1 with the high-affinity cellular receptor junction adhesion molecule-A (JAM-A). We previously demonstrated that the human glioblastoma cell line U-118 MG does not express JAM-A and resists reovirus T3D infection in standard cell culture conditions (SCCC). Heterologous JAM-A expression sensitises U-118 MG cells to reovirus T3D. Here we studied reovirus infection in U-118 MG cells grown in spheroid cultures with the premise that cells in such cultures resemble cells in tumours more than those grown under standard adherent cell culture conditions on a plastic surface. Although the U-118 MG cells in spheroids do not express JAM-A, they are susceptible to reovirus T3D infection. We show that this can be attributed to factors secreted by cells in the spheroids. The concentration of active extracellular proteases cathepsin B and L in the medium of spheroid cultures was increased 19- and 24-fold, respectively, as compared with SCCC. These enzymes can convert the reovirus particles into a form that can infect the U-118 MG cells independent of JAM-A. Taken together, these data demonstrate that infection of tumour cells by wild-type reovirus T3D is not strictly dependent on the expression of JAM-A on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739522     DOI: 10.1038/gt.2014.34

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  14 in total

1.  Replicating reoviruses with a transgene replacing the codons for the head domain of the viral spike.

Authors:  D J M van den Wollenberg; I J C Dautzenberg; W Ros; A D Lipińska; S K van den Hengel; R C Hoeben
Journal:  Gene Ther       Date:  2015-01-15       Impact factor: 5.250

Review 2.  Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.

Authors:  Zineb Belcaid; Martine L M Lamfers; Victor W van Beusechem; Rob C Hoeben
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

3.  Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging.

Authors:  Hong-Jun Cho; Sung-Jin Lee; Sung-Jun Park; Chang H Paik; Sang-Myung Lee; Sehoon Kim; Yoon-Sik Lee
Journal:  J Control Release       Date:  2016-06-24       Impact factor: 9.776

Review 4.  Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus.

Authors:  Vera Kemp; Rob C Hoeben; Diana J M van den Wollenberg
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

Review 5.  VSV based virotherapy in ovarian cancer: the past, the present and …future?

Authors:  Beata Urszula Orzechowska; Marcin Jędryka; Katarzyna Zwolińska; Rafał Matkowski
Journal:  J Cancer       Date:  2017-07-22       Impact factor: 4.207

Review 6.  Three-dimensional tumor cell cultures employed in virotherapy research.

Authors:  Linus D Kloker; Can Yurttas; Ulrich M Lauer
Journal:  Oncolytic Virother       Date:  2018-09-05

7.  Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

Authors:  Arjanneke F van de Merbel; Geertje van der Horst; Maaike H van der Mark; Selas T F Bots; Diana J M van den Wollenberg; Corrina M A de Ridder; Debra Stuurman; Tilly Aalders; Sigrun Erkens-Schulz; Nadine van Montfoort; Wouter R Karthaus; Niven Mehra; Minke Smits; Jack A Schalken; Wytske M van Weerden; Rob C Hoeben; Gabri van der Pluijm
Journal:  Cancer Gene Ther       Date:  2021-06-16       Impact factor: 5.854

Review 8.  Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.

Authors:  Adil Mohamed; Randal N Johnston; Maya Shmulevitz
Journal:  Viruses       Date:  2015-12-01       Impact factor: 5.048

9.  Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.

Authors:  Iris J C Dautzenberg; Sanne K van den Hengel; Jeroen de Vrij; Lars Ravesloot; Steve J Cramer; Saw-See Hong; Diana J M van den Wollenberg; Pierre Boulanger; Rob C Hoeben
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

10.  Expression and prognostic value of JAM-A in gliomas.

Authors:  Ann Mari Rosager; Mia D Sørensen; Rikke H Dahlrot; Henning B Boldt; Steinbjørn Hansen; Justin D Lathia; Bjarne W Kristensen
Journal:  J Neurooncol       Date:  2017-07-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.